Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas (Q24307530)

GOA release 2020-03-11

1 reference

3

Toyomasa Katagiri

0 references

author name string

Satoshi Nagayama

1

0 references

Chikako Fukukawa

2

0 references

Takeshi Okamoto

4

0 references

Tomoki Aoyama

5

0 references

Naoki Oyaizu

6

0 references

Masayuki Imamura

7

0 references

Junya Toguchida

8

0 references

Yusuke Nakamura

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

9

0 references

language of work or name

English

0 references

publication date

15 September 2005

0 references

published in

Oncogene

0 references

volume

24

0 references

issue

41

0 references

page(s)

6201-12

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Molecular mechanisms underlying human synovial sarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Current treatment of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780

inferred from DOI database lookup

7 January 2021

based on heuristic

The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208780